170 results on '"Epstein, Suzanne L."'
Search Results
2. The Regulatory Process and Gene Therapy 1
3. Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen
4. Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice
5. Protection against Lethal Influenza Virus Challenge by RNA Interference in vivo
6. First flu is forever
7. Survey of Human Antibody Responses to Influenza Virus Matrix Protein 2 by Use of a Sensitive Flow Cytometric Method
8. Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies
9. Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza
10. Heterosubtypic Immunity to Influenza: Right Hypothesis, Wrong Comparison [with Reply to Carrat and Lavenu]
11. Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature
12. Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice
13. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies
14. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model
15. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
16. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. (Research)
17. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine
18. Cross-protective immunity to influenza A viruses
19. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
20. Control of influenza virus infection by immunity to conserved viral features
21. Seven new MHC recombinant strains defining new H-2 haplotypes
22. The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice
23. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression
24. Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo
25. Use of Monoclonal Antibodies for Studies of Anti-Ia Receptor Idiotypes
26. Expression of Anti-MHC Idiotypes in Immune Responses
27. Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
28. Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice
29. Immunoglobulin classes and subclasses in alloantisera to mouse thymocyte surface antigens
30. Eight new MHC recombinant strains defining at least six H-2 haplotypes
31. Toll-Like Receptor 3-Specific dsRNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-presentation, CTL Responses and Antiviral Protection
32. Idiotypes of Anti-MHC Monoclonal Antibodies
33. Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic.
34. Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model
35. Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus
36. Intranasal Administration of Adeno-associated Virus Type 12 (AAV12) Leads to Transduction of the Nasal Epithelia and Can Initiate Transgene-specific Immune Response
37. Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice
38. TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
39. Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
40. Genetic control of immune responses to influenza A matrix 2 protein (M2)
41. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
42. Reply to Carrat and Lavenu
43. Critical Path Workshop on the Development of Cellular and Gene Therapy Products
44. Susceptibility and immunity to influenza A strains in Ig−/−mice
45. Vaccination with DNA encoding conserved influenza viral proteins
46. Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells
47. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge
48. Mechanism of Protective Immunity Against Influenza Virus Infection in Mice Without Antibodies
49. FDA research
50. Mouse Monoclonal Antibodies to Human Immunodeficiency Virus Glycoprotein 120 Generated by Repeated Immunization with Glycoprotein 120 from a Single Isolate, or by Sequential Immunization with Glycoprotein 120 from Three Isolates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.